Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, no par value $ 0 $ 0
Common stock, shares authorized Unlimited Unlimited
Common stock, shares issued 22,573,938 5,841,045
Common stock, shares outstanding 22,573,938 5,841,045